Insider · CIK 0001289946

Broom Colin MD

Reports to the SEC for 4 companies · BEDMINSTER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001289946

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-08-02	Nabriva Therapeutics plcS Sale	Director	SSale	−5,339 sh	$0.19	−$1,015.478	36,523
2021-08-02	Nabriva Therapeutics plcS Sale	Director	SSale	−531 sh	$1.20	−$637.2	41,862
2021-07-28	Nabriva Therapeutics plcA Award	Director	AAward	+17.5K sh	—	—	42,393
2021-07-28	Nabriva Therapeutics plcShare OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2020-08-20	Nabriva Therapeutics plcS Sale	Director	SSale	−11.1K sh	$0.65	−$7,165.046	248,936
2020-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+33.8K sh	—	—	260,000
2020-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−33.8K sh	—	—	0
2020-07-29	Nabriva Therapeutics plcStock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2020-07-29	Nabriva Therapeutics plcA Award	Director	AAward	+17.5K sh	—	—	226,250
2019-08-30	Nabriva Therapeutics plcP Purchase	Director	PPurchase	+10.2K sh	$2.03	+$20.7K	208,750
2019-08-21	Nabriva Therapeutics plcS Sale	Director	SSale	−10.2K sh	$2.07	−$21.1K	125,724
2019-08-21	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−10.2K sh	$2.07	−$21.1K	125,724
2019-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−33.8K sh	—	—	33,750
2019-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+33.8K sh	—	—	135,901
2019-07-31	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+35K sh	—	—	35,000
2018-06-22	Nabriva Therapeutics plcP Purchase	Director	PPurchase	+5,000 sh	$3.72	+$18.6K	102,151
2018-05-23	Nabriva Therapeutics plcP Purchase	Director	PPurchase	+10K sh	$4.60	+$46K	97,151
2018-01-31	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+67.5K sh	—	—	67,500
2018-01-31	Nabriva Therapeutics plcStock OptionsA Award	Director	AAward	+200K sh	—	—	200,000
2017-09-22	Nabriva Therapeutics plcP Purchase	Director	PPurchase	+2,588 sh	$8.35	+$21.6K	87,151
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director, Chief Executive Officer	JOther	+261K sh	—	—	261,000
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director, Chief Executive Officer	JOther	+151K sh	—	—	151,000
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director, Chief Executive Officer	JOther	+197K sh	—	—	196,900
2017-06-23	Nabriva Therapeutics Legacy plcJ Other	Director, Chief Executive Officer	JOther	+156K sh	—	—	155,817
2017-06-23	Nabriva Therapeutics Legacy plcJ Other	Director, Chief Executive Officer	JOther	+1,595 sh	—	—	1,595
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director, Chief Executive Officer	JOther	+158K sh	—	—	158,270
2017-02-07	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+26.1K sh	—	—	26,100
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCU Disposition from Tender	Director	UDisposition from Tender	−24.3K sh	$46.00	−$1.12M	0
2015-02-21	NPS PHARMACEUTICALS INCDeferred Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−29.8K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,816 sh	—	—	0
2015-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+3,816 sh	—	—	3,816
2014-02-13	NPS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+15.2K sh	—	—	24,313
2014-02-13	NPS PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.2K sh	—	—	0
2014-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+4,572 sh	—	—	4,572
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−40K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−32.5K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−34.6K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−27.3K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−40.3K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−40.3K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−50K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−36.9K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−52.6K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−50K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−35.7K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−33.4K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−34.9K sh	—	—	0
2014-01-24	VIROPHARMA INCD Disposition to Issuer	VP & Chief Scientific Officer	DDisposition to Issuer	−48.9K sh	—	—	0
2014-01-24	VIROPHARMA INCA Award	VP & Chief Scientific Officer	AAward	+48.9K sh	—	—	48,878

Recent filings

Accepted (ET)
Aug 44
Broom Colin MD0001104659-22-086280
SEC(opens sec.gov)
Aug 44
Broom Colin MD0001104659-21-100289
SEC(opens sec.gov)
Jul 304
Broom Colin MD0001104659-21-098428
SEC(opens sec.gov)
Aug 214
Broom Colin MD0001104659-20-097717
SEC(opens sec.gov)
Jul 314
Broom Colin MD0001104659-20-089136
SEC(opens sec.gov)
Sep 34
Broom Colin MD0001104659-19-048436
SEC(opens sec.gov)
Aug 264/A
Broom Colin MD0001104659-19-047351
SEC(opens sec.gov)
Aug 214
Broom Colin MD0001104659-19-046857
SEC(opens sec.gov)
Aug 14
Broom Colin MD0001104659-19-043342
SEC(opens sec.gov)
Jun 254
Broom Colin MD0001104659-18-041953
SEC(opens sec.gov)
May 234
Broom Colin MD0001104659-18-035535
SEC(opens sec.gov)
Feb 24
Broom Colin MD0001104659-18-006228
SEC(opens sec.gov)
Sep 264
Broom Colin MD0001104659-17-058896
SEC(opens sec.gov)

Companies

Address

550 HILLS DRIVE

BEDMINSTER, NJ, 07921